Phase 2 Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Down syndrome, including mosaic Down syndrome or partial trisomy 21.
- You are willing to sign a consent form (or have a legal representative sign on your behalf) and agree to follow all study requirements for the full length of the study.
- You are between 18 and 55 years old (inclusive).
- You are in generally good health with no diagnosis of dementia.
- Any medications that affect the brain have been at a stable dose for at least 4 weeks (if you recently started a new one, the study team will review your situation individually).
- You have enough vision and hearing to complete thinking and memory tests.
- If you are a female who has not had surgery to prevent pregnancy and have not been through menopause for at least two years, you must have a negative pregnancy test within 24 hours before a brain scan.
- You have a mental age of 4 years or older, based on a specific intelligence test (the KBIT-2).
- English is your first or native language.
- You have a reliable study partner (such as a caregiver, sibling, or parent) who can share information about your health history and symptoms.
Who may not be able to join:
- You have a serious or unstable medical condition that could affect thinking and memory tests, such as unstable heart problems, chronic kidney failure, chronic liver disease, or severe lung disease.
- You are unable to have an MRI scan — for example, if you have a pacemaker, metal fragments near your eyes or spine, or a cochlear implant (note: dental fillings are not a problem).
- You are unable to complete the MRI and PET brain scanning procedures required by the study.
- Your IQ score is below 40 on the KBIT-2 intelligence test.
- You are currently pregnant or breastfeeding.
- You have been diagnosed with cancer in the last 5 years, with some exceptions such as certain minor skin cancers that have been successfully treated (confirm with trial site).
- You have significantly abnormal vitamin B12 or thyroid levels that could interfere with the study, unless follow-up tests show these are not a real concern (confirm with trial site).
- You have other significantly abnormal results from your screening blood tests.
- If spinal fluid collection applies to you: you have a blood clotting or bleeding disorder, or abnormal clotting test results, or you take blood-thinning medication such as warfarin.
- The doctor leading the study at your location decides you are not suitable for another reason.
- You have a clinical diagnosis of dementia.
- You are currently taking part in another clinical trial for an experimental treatment, or another long-term study that uses similar tests or procedures.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alexander C Conley, Ph.D., Vanderbilt University Medical Center
Phone: 615-327-7117
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
[18F]-FEOBV radiotracer standardized uptake value ratio correlation with the Basal Forebrain Cholinergic System Volume.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.